Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1423053 MIAMI, FL
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$60,999,840
+$34,756,233 QoQ
Shares Held
747,822
+94.1% QoQ
Ownership
0.896%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#30
of 383 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Derivatives in PTCT

reported options exposure · as of Jun 30, 2026
CallValue
$530,205
CallShares
6,500
PutValue
$1,019,625
PutShares
12,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,739,871 across 435 Biotechnology names. PTCT ranks #26 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ONC
BeOne Medicines Ltd.
 1,425,517 $406,229,578
2 BBIO
BridgeBio Pharma, Inc.
 3,760,028 $280,046,885
3 INSM
INSMED Inc
 2,556,973 $272,624,460
4 MDGL
Madrigal Pharmaceuticals, Inc.
 507,233 $272,358,759
5 VRTX
Vertex Pharmaceuticals Inc / Ma
 510,430 $253,545,893
6 JAZZ
Jazz Pharmaceuticals plc
 1,006,676 $242,578,715
7 MANE
Veradermics, Inc
 1,877,775 $230,853,658
8 ROIV
Roivant Sciences Ltd.
 5,576,261 $197,343,876

All Filings in PTCT

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $530,205 6,500
2026-06-30 $60,999,840 747,822
2026-06-30 $1,019,625 12,500
2026-03-31 $1,185,462 17,400
2026-03-31 $26,243,607 385,199
2026-03-31 $742,617 10,900
2025-12-31 $888,732 11,700
2025-12-31 $87,692,401 1,154,455
2025-12-31 $577,296 7,600
2025-09-30 $1,472,880 24,000
2025-09-30 $521,645 8,500
2025-09-30 $106,233,003 1,731,025
2025-06-30 $590,964 12,100
2025-06-30 $1,699,632 34,800
2025-06-30 $44,956,878 920,493
2025-03-31 $626,808 12,300
2025-03-31 $438,256 8,600
2025-03-31 $59,501,966 1,167,621
2024-12-31 $762,866 16,900
2024-12-31 $20,674,796 458,015
2024-12-31 $234,728 5,200
2024-09-30 $8,871,685 239,129
2024-09-30 $211,470 5,700
2024-09-30 $549,080 14,800
2024-06-30 $8,259,015 270,079
2024-06-30 $143,726 4,700
2024-06-30 $262,988 8,600
2024-03-31 $2,926,454 100,600
2024-03-31 $824,352 28,338
2024-03-31 $180,358 6,200
2023-12-31 $567,736 20,600
2023-12-31 $8,017,699 290,918
2023-12-31 $223,236 8,100
2023-09-30 $156,870 7,000
2023-09-30 $2,810,348 125,406
2023-09-30 $181,521 8,100
2023-06-30 $569,380 14,000
2023-06-30 $296,891 7,300
2023-06-30 $3,022,105 74,308
2023-03-31 $1,472,576 30,400
2023-03-31 $1,259,440 26,000
2022-12-31 $95,425 2,500
2022-12-31 $53,247 1,395
2022-12-31 $1,248,159 32,700
2022-09-30 $1,425,680 28,400
2022-09-30 $5,286,060 105,300
2022-09-30 $19,225,846 382,985
2022-06-30 $757,134 18,900
2022-06-30 $5,031,536 125,600
2022-06-30 $3,044,359 75,995